🟢 Clearpoint Neuro is trading 10.75% up today — no clear company-specific catalyst identified

Clearpoint Neuro is trading 10.75% up at $16.80, with no clear company-specific catalyst identified for August 25, 2026.

• The latest listed company release was its August 3, 2026, second-quarter report, which reduced 2026 revenue guidance to $48 million–$52 million.
• The Nasdaq Composite is up 0.51%, suggesting broader risk-on sentiment may be contributing, but the company-specific reason remains unconfirmed.